Skip to search formSkip to main contentSkip to account menu

IL-10 Immunomodulator MK-1966

Known as: MK 1966, MK-1966 
An agent that downregulates the activity of the anti-inflammatory cytokine human interleukin-10 (IL-10), with potential immunomodulating and… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Development of the anti-IL-10 mAb MK-1966 in combination with in situ vaccination of a TLR9 agonist SD-101 for cancer immunotherapy
2016
2016
The Experience of Immunoflazidum in Complex Treatment of Various Forms of Herpes Virus Infections in the Children with Congenital Malformations of the Intestinal Tube
The article deals with the data on the incidence of infectious diseases and median parameters of cytokine status in children with… 
1998
1998
IgA B and T cells in the intestinal Villi of immunodeficient rats orally treated with thymomodulin.
Previous studies on the effect of the oral administration of bacterial immunomodulators (1M-104 and RN-301) during the protein… 
1996
1996
Antibabesial effect of the immunomodulator AS101 in mice: role of increased production of nitric oxide
The immunomodulator AS101 has been shown to induce cell proliferation and to increase the secretion of a variety of cytokines. In… 
1995
1995
Induction of acute phase proteins in mice and humans by treatment with AS101, an immunomodulator with radioprotective properties.
1994
1994
Restoration of murine cytomegalovirus (MCMV) induced myelosuppression by AS101.
1991
1991
Transplantation of Purified Islet Cells in Diabetic Rats: III. Immunosuppressive Effect of Cyclosporin
This study examined the effect of cyclosporin on the survival of islet β-cell allografts in streptozocin (STZ)-induced diabetic… 
1990
1990
The effect of the immunomodulator agent AS101 on interleukin‐2 production in systemic lupus erythematosus (SLE) induced in mice by a pathogenic anti‐DNA antibody
The role of the synthetic immunomodulator AS101 on the production of interleukin‐2 (IL‐2) by spleen cells of mice with SLE was… 
1986
1986
[Effect of thymalin on thrombocyte aggregation and the antiaggregation activity of the vascular wall in intact and thymectomized rats].
Administration of immunomodulator thymalin to intact rats was shown to produce reduction of platelet aggregation ability and to… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)